Shanghai New World Co., Ltd

SHSE:600628 주식 보고서

시가총액: CN¥4.5b

Shanghai New World 과거 수익 실적

과거 기준 확인 3/6

Shanghai New World's earnings have been declining at an average annual rate of -7.7%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 7.3% per year. Shanghai New World's return on equity is 1.1%, and it has net margins of 4%.

주요 정보

-7.7%

수익 성장률

-7.8%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률-7.3%
자기자본 수익률1.1%
순이익4.0%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Statutory Profit Doesn't Reflect How Good Shanghai New World's (SHSE:600628) Earnings Are

Apr 25
Statutory Profit Doesn't Reflect How Good Shanghai New World's (SHSE:600628) Earnings Are

Recent updates

Statutory Profit Doesn't Reflect How Good Shanghai New World's (SHSE:600628) Earnings Are

Apr 25
Statutory Profit Doesn't Reflect How Good Shanghai New World's (SHSE:600628) Earnings Are

Pinning Down Shanghai New World Co., Ltd's (SHSE:600628) P/S Is Difficult Right Now

Apr 16
Pinning Down Shanghai New World Co., Ltd's (SHSE:600628) P/S Is Difficult Right Now

수익 및 비용 분석

Shanghai New World 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SHSE:600628 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 241,134453320
30 Jun 241,142403350
31 Mar 241,145343390
31 Dec 231,134323290
30 Sep 231,075323370
30 Jun 231,049183230
31 Mar 23905-393060
31 Dec 22850-522940
30 Sep 22903-442760
30 Jun 22938-242900
31 Mar 221,106563080
31 Dec 211,166693250
30 Sep 211,1711332070
30 Jun 211,1681322520
31 Mar 211,1141082600
31 Dec 201,046713110
30 Sep 201,12944890
30 Jun 201,100-374830
31 Mar 201,133-584980
31 Dec 191,653374920
30 Sep 192,043824960
30 Jun 192,4311515080
31 Mar 192,7732275050
31 Dec 182,7762735070
30 Sep 182,8412705550
30 Jun 182,9482825510
31 Mar 182,9883055630
31 Dec 173,0224485580
30 Sep 173,0026325070
30 Jun 172,9685825190
31 Mar 172,9715095020
31 Dec 163,0182535040
30 Sep 163,034574190
30 Jun 163,060494130
31 Mar 163,090244180
31 Dec 153,114524260
30 Sep 153,2031144000
30 Jun 153,2131424030
31 Mar 153,2502324110
31 Dec 143,3332404070
30 Sep 143,4222434040
30 Jun 143,4322394100
31 Mar 143,4702454090
31 Dec 133,4502434060

양질의 수익: 600628 has a large one-off loss of CN¥28.5M impacting its last 12 months of financial results to 30th September, 2024.

이익 마진 증가: 600628's current net profit margins (4%) are higher than last year (2.9%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 600628's earnings have declined by 7.7% per year over the past 5 years.

성장 가속화: 600628's earnings growth over the past year (43.6%) exceeds its 5-year average (-7.7% per year).

수익 대 산업: 600628 earnings growth over the past year (43.6%) exceeded the Pharmaceuticals industry -1.2%.


자기자본 수익률

높은 ROE: 600628's Return on Equity (1.1%) is considered low.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기